Discovery of LYA914, An Orally Bioavailable PROTAC Degrader Targeting the DNA Binding Domain of the Androgen Receptor for the Treatment of CRPC

发表于 2026-7-27 17:30:07

期刊：Journal of Medicinal Chemistry

文献作者：Yan Lv; Gaoxin Dai; Bowen Zhang; Chang Liu; Yiming Chen; Ling Ge; Sai Zhang; Siqi Zhang; Mengjun Ma; Shumin Ma; Chong Qin

出版日期：--

DOI号：10.1021/acs.jmedchem.5c01463

下载链接：https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c01463

文献链接：https://doi.org/10.1021/acs.jmedchem.5c01463

当前文献来源于 American Chemical Society (ACS)。

备注信息：

发表于 2026-7-27 17:30:08

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ACS] Discovery of LYA914, An Orally Bioavailable PROTAC Degrader Targeting the DNA Binding Domain of the Androgen Receptor for the Treatment of CRPC

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ACS] Discovery of LYA914, An Orally Bioavailable PROTAC Degrader Targeting the DNA Binding Domain of the Androgen Receptor for the Treatment of CRPC 一键复制